Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume 36, Issue 1, Pages 32-91
Publisher
Wiley
Online
2015-09-11
DOI
10.1002/med.21377
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Quest for a Simple Bioactive Analog of Paclitaxel as a Potential Anticancer Agent
- (2014) David G. I. Kingston et al. ACCOUNTS OF CHEMICAL RESEARCH
- New Horizons for Old Drugs and Drug Leads
- (2014) Gordon M. Cragg et al. JOURNAL OF NATURAL PRODUCTS
- From Bacteria to Antineoplastic: Epothilones A Successful History
- (2013) Samuel Kaiser et al. Anti-Cancer Agents in Medicinal Chemistry
- Natural products: A continuing source of novel drug leads
- (2013) Gordon M. Cragg et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Carfilzomib
- (2013) K. M. Kortuem et al. BLOOD
- A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis
- (2013) Samira Sadat Abolmaali et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity
- (2013) A Kruczynski et al. LEUKEMIA
- Cabazitaxel: A Novel Drug for Hormone-Refractory Prostate Cancer
- (2013) Manav Malhotra et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- 2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products
- (2012) Alan D. Borthwick CHEMICAL REVIEWS
- Tanespimycin as Antitumor Therapy
- (2012) Meletios-Athanassios Dimopoulos et al. Clinical Lymphoma Myeloma & Leukemia
- Namitecan: a Hydrophilic Camptothecin with a Promising Preclinical Profile
- (2012) G. L. Beretta et al. CURRENT MEDICINAL CHEMISTRY
- Macrocycles in new drug discovery
- (2012) Jamie Mallinson et al. Future Medicinal Chemistry
- Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines
- (2012) Simon Mahoney et al. JOURNAL OF BIOSCIENCES
- Charting, Navigating, and Populating Natural Product Chemical Space for Drug Discovery
- (2012) Hugo Lachance et al. JOURNAL OF MEDICINAL CHEMISTRY
- Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
- (2012) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Phase-II Trial of Rebeccamycin Analog, a Dual Topoisomerase-I and -II Inhibitor, in Relapsed “Sensitive” Small Cell Lung Cancer
- (2012) Anita Schwandt et al. Journal of Thoracic Oncology
- Natural Products Based Anticancer Agents
- (2012) Biswanath Das et al. MINI-REVIEWS IN ORGANIC CHEMISTRY
- Triptolide: structural modifications, structure–activity relationships, bioactivities, clinical development and mechanisms
- (2012) Zhao-Li Zhou et al. NATURAL PRODUCT REPORTS
- Anticancer steroids: linking natural and semi-synthetic compounds
- (2012) Jorge A. R. Salvador et al. NATURAL PRODUCT REPORTS
- Natural-product-derived fragments for fragment-based ligand discovery
- (2012) Björn Over et al. Nature Chemistry
- Antitumor Effects of Somatostatin Analogs in Neuroendocrine Tumors
- (2012) L. Sideris et al. ONCOLOGIST
- Triphendiol (NV-196), development of a novel therapy for pancreatic cancer
- (2011) Xiaohong Wang et al. ANTI-CANCER DRUGS
- Classification of scaffold-hopping approaches
- (2011) Hongmao Sun et al. DRUG DISCOVERY TODAY
- Natural products: An evolving role in future drug discovery
- (2011) Bhuwan B. Mishra et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Relevance of Higher Plants in Lead Compound Discovery Programs
- (2011) A. Douglas Kinghorn et al. JOURNAL OF NATURAL PRODUCTS
- Eribulin mesylate
- (2011) Timothy K. Huyck et al. NATURE REVIEWS DRUG DISCOVERY
- Synthesis and Preclinical Evaluations of 2-(2-Fluorophenyl)-6,7-methylenedioxyquinolin-4-one Monosodium Phosphate (CHM-1−P-Na) as a Potent Antitumor Agent
- (2010) Li-Chen Chou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Development of Natural Product-Derived Chemotherapeutic Agents Based on a Medicinal Chemistry Approach⊥†
- (2010) Kuo-Hsiung Lee JOURNAL OF NATURAL PRODUCTS
- Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia
- (2010) J E Lancet et al. LEUKEMIA
- FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma
- (2010) V. E. Kwitkowski et al. ONCOLOGIST
- Molecular pharmacology and antitumor activity of Zalypsis ® in several human cancer cell lines
- (2009) Juan F.M. Leal et al. BIOCHEMICAL PHARMACOLOGY
- FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML
- (2009) K. W. Pratz et al. BLOOD
- CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer
- (2009) J E Ang et al. BRITISH JOURNAL OF CANCER
- Impact of Natural Products on Developing New Anti-Cancer Agents†
- (2009) Gordon M. Cragg et al. CHEMICAL REVIEWS
- Flavonoids, phenoxodiol, and a novel agent, triphendiol, for the treatment of pancreaticobiliary cancers
- (2009) M Wasif Saif et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma
- (2009) Paul A Meyers Expert Review of Anticancer Therapy
- Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule Repository
- (2009) Narender Singh et al. Journal of Chemical Information and Modeling
- Tubulin-Interactive Natural Products as Anticancer Agents(1)
- (2009) David G. I. Kingston JOURNAL OF NATURAL PRODUCTS
- Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor
- (2009) Wei-Gang Tong et al. LEUKEMIA RESEARCH
- Novel cytotoxic agents: Epothilones
- (2008) S. Goodin AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Structure–activity relationship studies on a novel class of antiproliferative agents derived from Lavendustin A. Part I: Ring A modifications
- (2008) Peter Nussbaumer et al. BIOORGANIC & MEDICINAL CHEMISTRY
- From nature to the laboratory and into the clinic
- (2008) K.C. Nicolaou et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Diflomotecan, a promising homocamptothecin for cancer therapy
- (2008) Judith R Kroep et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer
- (2008) Meghana Trivedi et al. Future Oncology
- Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies
- (2008) Monica M. Mita et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors
- (2008) Lillian L. Siu et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
- (2008) David J. Newman JOURNAL OF MEDICINAL CHEMISTRY
- Plant-derived natural product research aimed at new drug discovery
- (2008) Hideji Itokawa et al. Journal of Natural Medicines
- Natural products to drugs: natural product-derived compounds in clinical trials
- (2008) Mark S. Butler NATURAL PRODUCT REPORTS
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- Therapeutic effect against human xenograft tumors in nude mice by the third generation microtubule stabilizing epothilones
- (2008) T.-C. Chou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started